Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma (Cell Death Discovery, (2020), 6, 1, (114), 10.1038/s41420-020-00348-1)

Surein Arulananda, Megan O’Brien, Marco Evangelista, Tiffany J. Harris, Nikita S. Steinohrt, Laura J. Jenkins, Marzena Walkiewicz, Robert J.J. O’Donoghue, Ashleigh R. Poh, Bibhusal Thapa, David S. Williams, Trishe Leong, John M. Mariadason, Xia Li, Jonathan Cebon, Erinna F. Lee, Thomas John, W. Douglas Fairlie

Research output: Contribution to journalComment/debate

Abstract

The original version of this article unfortunately contained an error in the name of one of the authors (WD Fairlie). This has been corrected in the PDF and HTML versions. The original article has been corrected.

Original languageEnglish
Article number146
JournalCell Death Discovery
Volume7
Issue number1
DOIs
Publication statusPublished - Jun 2021
Externally publishedYes

Fingerprint

Dive into the research topics of 'Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma (Cell Death Discovery, (2020), 6, 1, (114), 10.1038/s41420-020-00348-1)'. Together they form a unique fingerprint.

Cite this